Arch Therapeutics, Inc. - OTCQB: ARTH


Arch Therapeutics, Inc. (Arch) is a biotechnology company developing an innovative, elegant, and superior approach to the rapid cessation of bleeding (hemostasis*) and control of fluid leakage (sealant) during surgery and trauma care. . The underlying technology, exclusively licensed from a leading university, supports an innovative platform of smart materials that fulfill the criteria as a solution for a specialized field we call, “stasis and barrier applications.”


20 William Street, Suite 270
Wellesley, Massachusetts 02481
United States

Get Directions

Upgrade Your Listing